• SENSEX
    NIFTY 50
Business

Alembic Pharma gets board approval to raise up to Rs 1,000 cr via QIP

Updated : July 27, 2020 03:56 PM IST

On May 22, the company's board had passed an enabling resolution to raise up to Rs 1,200 crore by issue of securities.
Alembic Pharmaceuticals has three research and development (R&D) facilities -- two in India's Vadodara and Hyderabad, and one in the US.
Alembic Pharma gets board approval to raise up to Rs 1,000 cr via QIP

You May Also Like

Live TV
Advertisement